HLA-related Intrinsic protein mediateCD-02818s immune tolerance
Anticancer drug (like Cisplatin) embedded in fucose-bound-carrier which is specific for the CA19-9 (fucosylated antigens) cancer cells produce
Anti-claudin-2 antibody improves IBD intestinal barrier destruction by claudin-2
Original lipid nano particles(LNPs) with INF stimulator(Cyclic-di-GMP) showed dramatic activity as a cancer adjuvant.
This repurposing drug specifically suppresses R-Spondin2-dependent abnormal activation of Wnt/β-catenin signaling in OA chondrocytes
Therapeutic response to PD-1/PD-L1 blockade can be predicted by using this biomarker expressing on cancer associated fibroblast (CAF)
Proteins/Peptides Can be Easily Functionalized
Against Peritoneal Dissemination, Lymph node/Liver metastases
Protection of active site by 2-nitroimidazole is released in hypoxia
RANKL fragment peptides treat psoriasis with reduced expression of inflammatory cytokines through Toll-like receptor 7/8 (TLR7/8) signaling pathway.